[PDF][PDF] Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients' B cells
The COVID-19 pandemic urgently needs therapeutic and prophylactic interventions. Here,
we report the rapid identification of SARS-CoV-2-neutralizing antibodies by high-throughput …
we report the rapid identification of SARS-CoV-2-neutralizing antibodies by high-throughput …
[HTML][HTML] Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines
…, X Li, W Song, J Wu, S Liu, X Li, Y Zhang, B Su, X Guo… - Cell research, 2021 - nature.com
SARS-CoV-2 variants could induce immune escape by mutations on the receptor-binding
domain (RBD) and N-terminal domain (NTD). Here we report the humoral immune response to …
domain (RBD) and N-terminal domain (NTD). Here we report the humoral immune response to …
Neutralizing antibody responses to severe acute respiratory syndrome coronavirus 2 in coronavirus disease 2019 inpatients and convalescent patients
X Wang, X Guo, Q Xin, Y Pan, Y Hu, J Li… - Clinical Infectious …, 2020 - academic.oup.com
Background Coronavirus disease 2019 (COVID-19) is a pandemic with no specific antiviral
treatments or vaccines. There is an urgent need for exploring the neutralizing antibodies from …
treatments or vaccines. There is an urgent need for exploring the neutralizing antibodies from …
Neutralizing antibodies responses to SARS-CoV-2 in COVID-19 inpatients and convalescent patients
X Wang, X Guo, Q Xin, Y Pan, J Li, Y Chu, Y Feng… - MedRxiv, 2020 - medrxiv.org
Background COVID-19 is a pandemic with no specific antiviral treatments or vaccines. The
urgent needs for exploring the neutralizing antibodies from patients with different clinical …
urgent needs for exploring the neutralizing antibodies from patients with different clinical …
Downregulated gene expression spectrum and immune responses changed during the disease progression in patients with COVID-19
…, L Qiao, Y Feng, L Pang, F Wei, X Guo… - Clinical infectious …, 2020 - academic.oup.com
Background The World Health Organization characterizes novel coronavirus disease 2019 (COVID-19),
which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-…
which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-…
[HTML][HTML] High-dimensional immune profiling by mass cytometry revealed immunosuppression and dysfunction of immunity in COVID-19 patients
…, L Pang, L Qiao, Y Feng, Y Ouyang, X Guo… - Cellular & molecular …, 2020 - nature.com
The outbreak of coronavirus disease 2019 (COVID-19) caused by the new virus SARS-CoV-2
has been announced as a public health emergency of international concern. 1-3 The …
has been announced as a public health emergency of international concern. 1-3 The …
Early detection of SARS-CoV-2 antibodies in COVID-19 patients as a serologic marker of infection
…, GF Gao, J Song, Y Peng, B Su, X Guo… - … diseases: an official …, 2020 - ncbi.nlm.nih.gov
Background Thousands of medical staff had been infected with SARS-CoV-2 virus with hundreds
of deaths reported. Such loss could be prevented if there is a serologic assay for SARS-…
of deaths reported. Such loss could be prevented if there is a serologic assay for SARS-…
[HTML][HTML] The inhibition of IL-2/IL-2R gives rise to CD8+ T cell and lymphocyte decrease through JAK1-STAT5 in critical patients with COVID-19 pneumonia
…, J Yin, Y Ouyang, L Pang, Y Feng, L Qiao, X Guo… - Cell death & …, 2020 - nature.com
Although most patients with COVID-19 pneumonia have a good prognosis, some patients
develop to severe or critical illness, and the mortality of critical cases is up to 61.5%. However, …
develop to severe or critical illness, and the mortality of critical cases is up to 61.5%. However, …
Early detection of severe acute respiratory syndrome coronavirus 2 antibodies as a serologic marker of infection in patients with coronavirus disease 2019
…, GF Gao, J Song, Y Peng, B Su, X Guo… - Clinical Infectious …, 2020 - academic.oup.com
Background Thousands of medical staff have been infected with severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), with hundreds of deaths reported. Such loss could be …
syndrome coronavirus 2 (SARS-CoV-2), with hundreds of deaths reported. Such loss could be …
[HTML][HTML] Trends in hepatitis B virus resistance to nucleoside/nucleotide analogues in North China from 2009–2016: a retrospective study
X Guo, J Wu, F Wei, Y Ouyang, Q Li, K Liu… - International journal of …, 2018 - Elsevier
Nucleos(t)ide analogues (NAs) are widely used in anti-hepatitis B virus (anti-HBV) therapy
for effective inhibition of HBV replication. However, HBV resistance to NAs has emerged, …
for effective inhibition of HBV replication. However, HBV resistance to NAs has emerged, …